Breast Cancer Screening Market Size, Share, Growth, Trends, and Global Industry Analysis: By Component (Reagents and Kits, Instruments, Software and Services), By Technology (Imaging, Biopsy, Genomic Tests, Blood Tests, Others), By Application (Screening, Diagnostic and Predictive, Prognostic, Research), By End User (Hospitals and Clinics, Diagnostic Centers, Academic and Reaserach Institutes, Others) and Region  

Breast Cancer Screening Market size was valued at US$ 4,287.3 million in 2023 and is poised to grow at a CAGR of 6.8% from 2024 to 2030. Breast cancer is one of the most commonly occurring cancers among the women population across the globe. The key factors driving the market are technological advancements in screening technologies such as digital mammography, increasing prevalence of breast cancer worldwide, and government screening programs for breast cancer diagnosis are anticipated to drive the market over the forecast period. Additionally, Factors responsible for the growth of the market include the rising awareness about the early detection of breast cancer and the increasing incidence of breast cancer. For instance, according to American Cancer Society estimations, more than 310,000 cases of invasive breast cancer cases will be diagnosed in 2024. In the meantime, there is an increasing necessity for breast cancer screening tests in the developing and developed nations.

Furthermore, the rising R&D expenditure by the key players and the development of innovative strategies are predicted to drive market growth through the forecast period. For instance, in March 2022, LifeCell Inaugurated Breast Screen Panel, a comprehensive genetic screening test assessing women's danger of breast cancer. Such innovative testing methods lead to augmented adoption of breast cancer screening, driving the market growth. However, the high cost associated with breast cancer screening equipment, pain during the procedure, and radiation exposure from the mammography test remain substantial barriers that hamper the growth of the market in the forecast period. However, the key opportunities associated with the market are the rising government initiatives and support. Early detection of breast cancer can lead to sought-after outcomes, including augmented survival rate, many treatment options, and improved quality of life.

Breast Cancer Screening Market Key Developments

• In March 2022, Life Cell Inaugurated Breast Screen Panel, an inclusive genetic screening test that measures the risk of breast cancer in women.